Business Description
Hemogenyx Pharmaceuticals PLC
ISIN : GB00BYX3WZ24
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 1.05 | |||||
Debt-to-EBITDA | -0.51 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -6.3 | |||||
3-Year FCF Growth Rate | -6.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.11 | |||||
9-Day RSI | 53.17 | |||||
14-Day RSI | 52.15 | |||||
6-1 Month Momentum % | -41.38 | |||||
12-1 Month Momentum % | -34.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.33 | |||||
Quick Ratio | 3.33 | |||||
Cash Ratio | 1.91 | |||||
Days Payable | 73.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.4 | |||||
Shareholder Yield % | -27.37 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -205.71 | |||||
ROA % | -98.29 | |||||
ROIC % | -119.66 | |||||
3-Year ROIIC % | -156.07 | |||||
ROC (Joel Greenblatt) % | -170.19 | |||||
ROCE % | -104.92 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 6.5 | |||||
EV-to-EBIT | -3.63 | |||||
EV-to-EBITDA | -4.04 | |||||
EV-to-FCF | -3.07 | |||||
Earnings Yield (Greenblatt) % | -27.55 | |||||
FCF Yield % | -28.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hemogenyx Pharmaceuticals PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.007 | ||
Beta | 1.41 | ||
Volatility % | 143.63 | ||
14-Day RSI | 52.15 | ||
14-Day ATR (€) | 0.000703 | ||
20-Day SMA (€) | 0.0094 | ||
12-1 Month Momentum % | -34.62 | ||
52-Week Range (€) | 0.0075 - 0.052 | ||
Shares Outstanding (Mil) | 1,341.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hemogenyx Pharmaceuticals PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hemogenyx Pharmaceuticals PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Hemogenyx Pharmaceuticals PLC Frequently Asked Questions
What is Hemogenyx Pharmaceuticals PLC(FRA:5HU)'s stock price today?
When is next earnings date of Hemogenyx Pharmaceuticals PLC(FRA:5HU)?
Does Hemogenyx Pharmaceuticals PLC(FRA:5HU) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |